Clinical Trial Update: Evaluate the Efficacy and Safety of the ADVAGRAF® [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating efficacy and safety of ADVAGRAF in liver transplantation recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Advagraf (tacrolimus)

Snippet

Sponsor: Linical Korea | Conditions: Evidence of Liver Transplantation | Phase 4 | Status: COMPLETED